256 related articles for article (PubMed ID: 24755353)
1. Early acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP.
Mierzejewska B; Schroder PM; Baum CE; Blair A; Smith C; Duquesnoy RJ; Marrari M; Gohara A; Malhotra D; Kaw D; Liwski R; Rees MA; Stepkowski S
Hum Immunol; 2014 Aug; 75(8):703-8. PubMed ID: 24755353
[TBL] [Abstract][Full Text] [Related]
2. Acute Antibody-Mediated Rejection by De Novo Anti-HLA-DPβ and -DPα Antibodies After Kidney Transplantation: A Case Report.
Thammanichanond D; Parapiboon W; Mongkolsuk T; Worawichawong S; Tammakorn C; Kitpoka P
Transplant Proc; 2018 Oct; 50(8):2548-2552. PubMed ID: 30316396
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
[TBL] [Abstract][Full Text] [Related]
4. Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.
Bartel G; Wahrmann M; Schwaiger E; Kikić Ž; Winzer C; Hörl WH; Mühlbacher F; Hoke M; Zlabinger GJ; Regele H; Böhmig GA
Transpl Int; 2013 Feb; 26(2):121-30. PubMed ID: 23145861
[TBL] [Abstract][Full Text] [Related]
5. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against HLA-DP recognize broadly expressed epitopes.
Simmons DP; Kafetzi ML; Wood I; Macaskill PC; Milford EL; Guleria I
Hum Immunol; 2016 Dec; 77(12):1128-1139. PubMed ID: 27664843
[TBL] [Abstract][Full Text] [Related]
7. The role of HLA-DP mismatches and donor specific HLA-DP antibodies in kidney transplantation: a case series.
Daniëls L; Claas FHJ; Kramer CSM; Senev A; Vanden Driessche M; Emonds MP; Van Laecke S; Hellemans R; Abramowicz D; Naesens M
Transpl Immunol; 2021 Apr; 65():101287. PubMed ID: 32194154
[TBL] [Abstract][Full Text] [Related]
8. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
[TBL] [Abstract][Full Text] [Related]
9. Kidney Transplantation With Ultralong-Term (42 Years) Survival of a 100-Year-Old Graft.
Nascimento E; Lucas-Junior FM; Fabreti-Oliveira RA; Vilela B; Tavora ER; Silva JP; Salomão-Filho A
Transplant Proc; 2016 Nov; 48(9):3079-3084. PubMed ID: 27932151
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
[TBL] [Abstract][Full Text] [Related]
11. Positive virtual crossmatch with negative flow crossmatch results in two cases.
Jacob EK; De Goey SR; Gandhi MJ
Transpl Immunol; 2011 Jul; 25(1):77-81. PubMed ID: 21641997
[TBL] [Abstract][Full Text] [Related]
12. Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation.
Bachelet T; Martinez C; Del Bello A; Couzi L; Kejji S; Guidicelli G; Lepreux S; Visentin J; Congy-Jolivet N; Rostaing L; Taupin JL; Kamar N; Merville P
Transplantation; 2016 Jan; 100(1):159-66. PubMed ID: 26262501
[TBL] [Abstract][Full Text] [Related]
13. Epitope Analysis Aids in Transplant Decision Making by Determining the Clinical Relevance of Apparent Pre-Transplant Donor Specific Antibodies (DSA).
Pandey S; Harville TO
Ann Clin Lab Sci; 2019 Jan; 49(1):50-56. PubMed ID: 30814077
[TBL] [Abstract][Full Text] [Related]
14. Unintended Consequences of the New National Kidney Allocation Policy in the United States.
Tambur AR; Haarberg KM; Friedewald JJ; Leventhal JR; Cusick MF; Jaramillo A; Abecassis MM; Kaplan B
Am J Transplant; 2015 Sep; 15(9):2465-9. PubMed ID: 26137963
[TBL] [Abstract][Full Text] [Related]
15. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.
Moktefi A; Parisot J; Desvaux D; Canoui-Poitrine F; Brocheriou I; Peltier J; Audard V; Kofman T; Suberbielle C; Lang P; Rondeau E; Grimbert P; Matignon M
Transpl Int; 2017 Mar; 30(3):277-287. PubMed ID: 27992962
[TBL] [Abstract][Full Text] [Related]
16. Misidentification of preformed anti-HLA-DP antibodies leads to antibody-mediated kidney transplant rejection: a case report.
Thammanichanond D; Tammakorn C; Ingsathit A; Worawichawong S; Sangkum P
BMC Nephrol; 2022 May; 23(1):187. PubMed ID: 35581569
[TBL] [Abstract][Full Text] [Related]
17. Allorecognition of HLA-DP by CD4+ T cells is affected by polymorphism in its alpha chain.
Lauterbach N; Crivello P; Wieten L; Zito L; Groeneweg M; Voorter CE; Fleischhauer K; Tilanus MG
Mol Immunol; 2014 May; 59(1):19-29. PubMed ID: 24462895
[TBL] [Abstract][Full Text] [Related]
18. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure.
Malheiro J; Santos S; Tafulo S; Dias L; Martins S; Fonseca I; Almeida M; Pedroso S; Beirão I; Castro-Henriques A; Cabrita A
Transplantation; 2018 Nov; 102(11):1943-1954. PubMed ID: 29757900
[TBL] [Abstract][Full Text] [Related]
19. HLA-DPB1 and DPA1 ~ DPB1 linkage mismatch affects the survival of recipients receiving HLA-14/14 matched unrelated donor HSCT.
Liu S; Zhang T; Wu X; Yuan X; Zhu W; Chen L; Jiang X; Yang T; Li Y; Wang L; Gong Y; Wu D; Bao X; He J
HLA; 2024 Jun; 103(6):e15542. PubMed ID: 38887889
[TBL] [Abstract][Full Text] [Related]
20. Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1.
Fleischhauer K; Fernandez-Viña MA; Wang T; Haagenson M; Battiwalla M; Baxter-Lowe LA; Ciceri F; Dehn J; Gajewski J; Hale GA; Heemskerk MB; Marino SR; McCarthy PL; Miklos D; Oudshoorn M; Pollack MS; Reddy V; Senitzer D; Shaw BE; Waller EK; Lee SJ; Spellman SR
Bone Marrow Transplant; 2014 Sep; 49(9):1176-83. PubMed ID: 24955785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
